Innovation Partners
A massive thank you to the companies and organizations that brings together our community of innovators shaping the future of the clinical trial industry.
We’re already working with potential Partners for our next conference in 2025. Start a conversation with our team to learn how you can invest and directly support these critical conversations.
Our Official Partners for 2025
presenting sponsor
YPrime streamlines the clinical trial journey with a configurable platform designed for speed, quality, and certainty. With 50% faster IRT startup times, up to 30% faster eCOA launch times, and quality standards 50% above the industry average. YPrime helps solve for certainty.
ACRO advocates as the collective voice of innovative clinical research and technology organizations to regulators and policymakers, educating stakeholders and advocating for policies that foster efficient, effective and safe conduct of clinical research.
Through focused insights and execution, Endo develops and delivers life-enhancing therapies. Endo’s team members collaborate to bring forward pharmaceutical solutions that make a real difference for customers and patients.
CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people.
Lokavant was born within Biopharma to improve clinical trial performance by providing study teams with a Clinical Trial Intelligence Platform that delivers real-time, AI-driven data insights to enable researchers to design, plan, and execute trials more efficiently while boosting their confidence in making well-informed decisions.
Florence Healthcare is a leading provider of the Site Enablement Platform, committed to accelerating cures by better connecting sponsors, CROs, and research sites.
The company's integrated platform streamlines the clinical trial process, enabling seamless collaboration and more efficient management of clinical research workflows. Florence Healthcare is dedicated to fostering innovation and improving patient outcomes worldwide with over 12,000 connected research sites on its platform in 45 countries, facilitating more than 6.5 million research workflows every month.
Diligent Pharma is redefining vendor qualification and management within the clinical trial landscape through its tech-enabled, centralized quality and risk management platform. By integrating regulatory compliance expertise with a secure technology solution, Diligent provides a one-stop resource for managing vendor discovery, risk assessment, selection, and oversight activities.
The Diligent platform, firmly rooted in the ICH Vendor Risk Management Framework, houses qualification packages and risk assessments for hundreds of vendors across 32 clinical trial service categories. Global regulatory authorities accept Diligent's centralized model as a valid approach to vendor qualification and oversight, allowing sponsors to save significant time by eliminating redundant steps through a system that ensures compliance and supports smarter, data-informed decision-making.
Clinigen Clinical Supplies Management combines market-leading clinical trial supplies such as packaging and labelling, global storage and distribution, comparator sourcing, as well as biological sample management services such as sample storage.
Part of Clinigen’s global supply chain facility and depot network, Clinigen Clinical Supplies Management delivers tailored solutions for clients to ensure their clinical trials are a success, regardless of the size, scope, or stage of the projects.
They provide their clients access to 25+ years of clinical supply expertise and industry best cycle times.
Medidata was founded more than 25 years ago with the hope of powering smarter treatments and healthier people. Today, Medidata leads the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. Medidata, a Dassault Systèmes company, is headquartered in New York City and has offices around the world to meet the needs of its customers.
KPS Life specializes in outsourced solutions that can be curated for pharmaceutical clinical trials from Phase I through Phase IV, by affording access to an extensive network of functional and therapeutic experts.
KPS Life’s embedded resourcing model focuses on the economics of delivery while maintaining the standardization and consistency necessary to drive high-quality data output and efficiencies from engaging our broad spectrum of agile FSP solutions.
ESPERO is reimagining the future of clinical trials by tackling one of the industry’s biggest bottlenecks: protocol development. With a bold mission to cut protocol timelines by 30%, ESPERO is leading the charge in digitizing and streamlining the clinical trial process.
By transforming protocol creation into a modern, data-driven workflow, ESPERO empowers study sponsors to reduce delays, improve compliance, and accelerate scientific progress. At the core of their vision is a fully integrated digital data flow (DDF) that connects planning to execution—enabling faster, more efficient trials across the entire development lifecycle.
ESPERO is setting a new standard for clinical development—bridging the gap between today’s challenges and tomorrow’s innovations.
The Playbook helps companies bridge the gap between founder-led sales and a scalable, repeatable revenue strategy. With a focus on product-market fit and early customer traction, The Playbook ensures your team stays aligned on the path to growth—and ready for key milestones like fundraising.
Acting as a fractional Customer Development Team Leader, The Playbook brings a hands-on, strategic approach to building a winning business model. From identifying ideal customer segments to capturing high-value clients, they apply a proven framework designed to accelerate market validation and revenue generation.
Backed by deep expertise in scientific marketing, digital content, and CRM-driven lead generation, The Playbook integrates seamlessly with your company’s goals. Their flexible retention model includes equity participation, and their trusted network spans IP strategy, capital raises, and investment banking—giving early-stage teams the strategic edge they need to scale.